Fellowship · Rochester, MN
Sponsored by Mayo Clinic College of Medicine and Science
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia · 2022 · 3,300 citations · Shaji Kumar
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood · 2022 · 2,489 citations · Naseema Gangat
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Aakash Desai
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood · 2022 · 1,363 citations · Stephen Ansell, Shaji Kumar
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
The New England journal of medicine · 2021 · 2,130 citations · Yi Lin
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 560 citations ·
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,286 citations · Joleen Hubbard, Katrina Pedersen
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Lancet (London, England) · 2021 · 1,514 citations · Yi Lin